Shaping tomorrow: a deep dive into the role of decentralized clinical trials in Epilepsy research
Round table event ahead of the Epilepsy pipeline conference
We invite you to join our interactive round-table event ‘Shaping tomorrow: a deep dive into the role of decentralized clinical trials in Epilepsy research’. Discover the future of Epilepsy trials at our invitation only meeting. Join us as we delve into the transformative world of decentralized clinical trials, unlocking new possibilities and insights in epilepsy research. Save the date for an engaging discussion you won't want to miss.
- Reasons to consider DCTs in epilepsy research
- Developments to support DCT
- 100% decentralised, is it feasible?
- Decide upon next steps
Reasons to consider DCTs in epilepsy research
L.G. Exalto MD PhD, neurologist and scientific officer Julius Clinical
Are investigators interested in DCT; barriers and facilitators.
US: Prof. J. French, president of the Epilepsy study consortium
Europe: Prof. A. Arzimanoglou , co-chair of European Consortium of Epilepsy Trials.
100% decentralised, is it feasible?
Europe: Project Manager of Julius Clinical
Coordinator perspective: focus group feedback on DCTs in epilepsy
US: Meryl Lozano, MBE, Co-Executive Director at Epilepsy Study Consortium
Lived experiences
Patient, T.B.A.
Sponsor, T.B.A.
Round table discussion: to decide upon next steps
   
 
Patients/Caregivers, Sponsors , Regulatory Authorities, Epilepsy focused vendors